Clinical trial number NCT00080756 for "Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease" at ClinicalTrials.gov
Clinical trial number NCT00001521 for "Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia" at ClinicalTrials.gov
doi.org
McCue PM, Farquhar VJ, Carnevale EM, Squires EL (September 2002). "Removal of deslorelin (Ovuplant) implant 48 h after administration results in normal interovulatory intervals in mares". Theriogenology. 58 (5): 865–70. doi:10.1016/s0093-691x(02)00923-8. PMID12212887.
europa.eu
ema.europa.eu
"Suprelorin EPAR". European Medicines Agency. 11 July 2007. Retrieved 15 June 2024.
McCue PM, Farquhar VJ, Carnevale EM, Squires EL (September 2002). "Removal of deslorelin (Ovuplant) implant 48 h after administration results in normal interovulatory intervals in mares". Theriogenology. 58 (5): 865–70. doi:10.1016/s0093-691x(02)00923-8. PMID12212887.